Bead-Selected Antitumor Genetic Cell Vaccines
Cancer vaccines have always been in the scope of gene therapy research. One of the most successful approaches has been working with genetically modified tumor cells. However, to become a clinical reality, tumor cells must suffer a long and risky process from the extraction from the patient to the re...
Main Authors: | Herrero Mj, R Botella, R Algás, FM Marco, Aliño Sf |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2008-01-01
|
Series: | Clinical Medicine Insights: Oncology |
Online Access: | https://doi.org/10.4137/CMO.S586 |
Similar Items
-
Antitumor Cell-Complex Vaccines Employing Genetically Modified Tumor Cells and Fibroblasts
by: Antonio Miguel, et al.
Published: (2014-02-01) -
Comparative Antitumor Effect of Preventive versus Therapeutic Vaccines Employing B16 Melanoma Cells Genetically Modified to Express GM-CSF and B7.2 in a Murine Model
by: Salvador F. Aliño, et al.
Published: (2012-10-01) -
Development and Characterization of Calcium-Alginate Beads of Apigenin: In Vitro Antitumor, Antibacterial, and Antioxidant Activities
by: Mohammed F. Aldawsari, et al.
Published: (2021-08-01) -
Fueling Cancer Vaccines to Improve T Cell-Mediated Antitumor Immunity
by: Rosmely Hernandez, et al.
Published: (2022-05-01) -
Integration of Magnetic Bead-Based Cell Selection into Complex Isolations
by: Hannah M. Pezzi, et al.
Published: (2018-04-01)